ATACAND PLUS

This brand name is authorized in Australia, Austria, Canada, Cyprus, Ecuador, Estonia, Finland, Germany, Ireland, Israel, Malta, Mexico, Netherlands, Nigeria, Singapore, South Africa, Spain, Turkey.

Active ingredients

The drug ATACAND PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Candesartan UNII R85M2X0D68 - CANDESARTAN CILEXETIL
	Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration.
	Read more about Candesartan
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA06	Candesartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8504N, 9314F, 9315G
CA	Health Products and Food Branch	02244021, 02332922, 02332957
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00597647, 00986107, 00986113, 00986136, 01581660, 01581737, 04152853, 04152876, 04649022, 05107984, 05108096, 05108216, 05108334, 05108452, 05356546, 06102397, 06102428, 07548072, 07548184, 07573992, 07628948, 07628954, 09042891, 12652268, 13922787, 13922793, 17164912
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	H6490913, H6600913
EE	Ravimiamet	1132568, 1132579, 1132580, 1132591, 1132603, 1132614, 1132625, 1132636, 1132647, 1132658, 1393679, 1393680, 1393691, 1393703, 1393714, 1393725, 1393736, 1393747, 1393758, 1393769, 1393770, 1393781, 1393792, 1393804, 1393815, 1393826, 1393837, 1393848, 1393859, 1393860, 1594414
ES	Centro de información online de medicamentos de la AEMPS	63209, 71062, 71068
FI	Lääkealan turvallisuus- ja kehittämiskeskus	029706, 029729, 057042
IE	Health Products Regulatory Authority	13818, 14013, 15405, 15437
IL	מִשְׂרַד הַבְּרִיאוּת	6445
MT	Medicines Authority	AA908/09702
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	401M2001
NG	Registered Drug Product Database	A4-1470, A4-9456, B4-0338
Switch country to Nigeria in order to find specific presentations of ATACAND PLUS
NL	Z-Index G-Standaard, PRK	56170
SG	Health Sciences Authority	11383P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699786010055
ZA	Health Products Regulatory Authority	43/7.1.3/0923